Neutralization breadth of SARS CoV-2 viral variants following primary series and booster SARS CoV-2 vaccines in patients with cancer

Vivek Naranbhai, Kerri J St. Denis, Evan C Lam, Onosereme Ofoman, Wilfredo-Garcia Beltran, Cristhian Berrios, Atul K. Bhan, Justin F. Gainor, Alejandro B. Balazs, A. John Iafrate on behalf of the CANVAX team
doi: https://doi.org/10.1101/2021.11.10.21265988

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Back to top
Posted November 11, 2021.
Download PDF
Data/Code
Email
Neutralization breadth of SARS CoV-2 viral variants following primary series and booster SARS CoV-2 vaccines in patients with cancer
Vivek Naranbhai, Kerri J St. Denis, Evan C Lam, Onosereme Ofoman, Wilfredo-Garcia Beltran, Cristhian Berrios, Atul K. Bhan, Justin F. Gainor, Alejandro B. Balazs, A. John Iafrate
medRxiv 2021.11.10.21265988; doi: https://doi.org/10.1101/2021.11.10.21265988
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area